AI assistant
Sending…
Edwards Lifesciences Corp — Director's Dealing 2021
May 26, 2021
30042_dirs_2021-05-25_5594c995-1966-47f4-9d7e-8701560a32e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-05-25
Reporting Person: Szyman Catherine M. (CVP, Critical Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-25 | Common Stock | S | 4665.4212 | $96.0900 | Disposed | 29765.7936 | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.
More from Edwards Lifesciences Corp
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 8
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 17